| 000 | 01731 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516043701.0 | ||
| 264 | 0 | _c20120625 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1435-4373 | ||
| 024 | 7 |
_a10.1007/s10096-011-1307-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosentul, D C | |
| 245 | 0 | 0 |
_aThe impact of caspase-12 on susceptibility to candidemia. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cMar 2012 |
||
| 300 |
_a277-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBlack or African American _xgenetics |
| 650 | 0 | 4 |
_aCandida _xpathogenicity |
| 650 | 0 | 4 |
_aCandidemia _xgenetics |
| 650 | 0 | 4 |
_aCaspase 12 _xgenetics |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xblood |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aInterleukin-8 _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSepsis _xblood |
| 700 | 1 | _aPlantinga, T S | |
| 700 | 1 | _aScott, W K | |
| 700 | 1 | _aAlexander, B D | |
| 700 | 1 | _avan de Geer, N M D | |
| 700 | 1 | _aPerfect, J R | |
| 700 | 1 | _aKullberg, B J | |
| 700 | 1 | _aJohnson, M D | |
| 700 | 1 | _aNetea, M G | |
| 773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 31 _gno. 3 _gp. 277-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10096-011-1307-x _zAvailable from publisher's website |
| 999 |
_c20959937 _d20959937 |
||